2010
MM4TB, European Union Framework 7 (FP07) Grant for systems biology input for the discovery of novel medicines for TB
2010
KETO-Reductase metabolic engineering
2011
NC4; WELLCOME TRUST Affordable health care, in partnership with astrazeneca, grant for discovering novel combinations for TB
2012
DBT-BIPP Grant for green chemistry using biotransformation
2013
UK-BBSRC & DBT Grant for modeling clostridium
2014
Discovery of novel combinations for tuberculosis through NIH contract services, USA
2014
BIG Grant: Reverse MOA For deciphering the target for anti-bacterial compounds emerging from phenotypic screens
2014
DBT-BIPP grant for “Structure based strategy to ameliorate antibiotic efflux and enhance efficacy”
2016
DBT-BIPP Continuing grant for “Structure based strategy to ameliorate antibiotic efflux and enhance efficacy”
2017
Bugworks gets CARB-X funding
2018
Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding
2019
CARB-X Continuing grant for preclinical development
2021
CARB-X Continuing grant for preclinical development
2022
GARDP grant to support a part of Phase-1 Clinical Trial
2023
CARB-X Continuing grant for Phase-1 Clinical Trial
